Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 September 2007, Vol. 110, No. 5, pp. 1439-1447.
Prepublished online as a Blood First Edition Paper on April 27, 2007; DOI 10.1182/blood-2007-02-075598.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Figure
Right arrow All Versions of this Article:
blood-2007-02-075598v1
110/5/1439    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alter, B. P.
Right arrow Articles by Lansdorp, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alter, B. P.
Right arrow Articles by Lansdorp, P. M.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL TRIALS AND OBSERVATIONS

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Blanche P. Alter1, Gabriela M. Baerlocher2, Sharon A. Savage1, Stephen J. Chanock3, Babette B. Weksler4, Judith P. Willner5, June A. Peters1, Neelam Giri1, and Peter M. Lansdorp6

1 Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; 2 Hematology, University Hospital, Berne, Switzerland; 3 Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; 4 Department of Medicine, Weill Medical College, New York, NY; 5 Department of Genetics, Mount Sinai School of Medicine, New York, NY; 6 Terry Fox Laboratory, British Columbia Cancer Research Center, Vancouver, Canada

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome in which the known susceptibility genes (DKC1, TERC, and TERT) belong to the telomere maintenance pathway; patients with DC have very short telomeres. We used multicolor flow fluorescence in situ hybridization analysis of median telomere length in total blood leukocytes, granulocytes, lymphocytes, and several lymphocyte subsets to confirm the diagnosis of DC, distinguish patients with DC from unaffected family members, identify clinically silent DC carriers, and discriminate between patients with DC and those with other bone marrow failure disorders. We defined "very short" telomeres as below the first percentile measured among 400 healthy control subjects over the entire age range. Diagnostic sensitivity and specificity of very short telomeres for DC were more than 90% for total lymphocytes, CD45RA+/CD20– naive T cells, and CD20+ B cells. Granulocyte and total leukocyte assays were not specific; CD45RA– memory T cells and CD57+ NK/NKT were not sensitive. We observed very short telomeres in a clinically normal family member who subsequently developed DC. We propose adding leukocyte subset flow fluorescence in situ hybridization telomere length measurement to the evaluation of patients and families suspected to have DC, because the correct diagnosis will substantially affect patient management.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
D. Hockemeyer, W. Palm, R. C. Wang, S. S. Couto, and T. de Lange
Engineered telomere degradation models dyskeratosis congenita
Genes & Dev., July 1, 2008; 22(13): 1773 - 1785.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. T. Calado and N. S. Young
Telomere maintenance and human bone marrow failure
Blood, May 1, 2008; 111(9): 4446 - 4455.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. D. Goldman, G. Aubert, A. J. Klingelhutz, M. Hills, S. R. Cooper, W. S. Hamilton, A. J. Schlueter, K. Lambie, C. J. Eaves, and P. M. Lansdorp
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Blood, May 1, 2008; 111(9): 4523 - 4531.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Aubert and P. M. Lansdorp
Telomeres and Aging
Physiol Rev, April 1, 2008; 88(2): 557 - 579.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. M. Lansdorp
Telomeres, stem cells, and hematology
Blood, February 15, 2008; 111(4): 1759 - 1766.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
B. P. Alter
Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Hematology, January 1, 2007; 2007(1): 29 - 39.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020